12-92422628-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The ENST00000646751.1(CLLU1-AS1):​n.63C>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

CLLU1-AS1
ENST00000646751.1 non_coding_transcript_exon

Scores

2
17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -0.00800
Variant links:
Genes affected
CLLU1-AS1 (HGNC:24070): (CLLU1 antisense RNA 1)
CLLU1 (HGNC:29841): (chronic lymphocytic leukemia up-regulated 1) Expression of this gene has been shown to be upregulated in some individuals with chronic lymphocytic leukemia (CLL), and has been used for prognostic and diagnostic purposes. This gene was originally identified as a human-specific putative protein-coding gene due to the presence of a peptide (PAp00140670, HIIYSTFLSK) that could have supported translation at this locus. This peptide is not present in more recent builds of PeptideAtlas, and the presence of a protein product at this locus has not been independently verified. For this reason, this gene is being represented as non-coding. Sequence comparisons to other primates indicates that no other primate is predicted to contain an open reading frame. [provided by RefSeq, Feb 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.084570795).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
CLLU1NR_027932.1 linkuse as main transcriptn.305+793G>C intron_variant, non_coding_transcript_variant
CLLU1-AS1NR_144319.2 linkuse as main transcriptn.91-1455C>G intron_variant, non_coding_transcript_variant
CLLU1-AS1NR_164161.1 linkuse as main transcriptn.63C>G non_coding_transcript_exon_variant 2/4
CLLU1NR_027933.1 linkuse as main transcriptn.305+793G>C intron_variant, non_coding_transcript_variant

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
CLLU1-AS1ENST00000646751.1 linkuse as main transcriptn.63C>G non_coding_transcript_exon_variant 2/4
CLLU1ENST00000472839.6 linkuse as main transcriptn.305+793G>C intron_variant, non_coding_transcript_variant 1
CLLU1ENST00000512817.1 linkuse as main transcriptn.305+793G>C intron_variant, non_coding_transcript_variant 1
CLLU1ENST00000589406.1 linkuse as main transcriptn.1098G>C non_coding_transcript_exon_variant 1/1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJul 06, 2021The c.61C>G (p.Q21E) alteration is located in exon 2 (coding exon 2) of the CLLU1OS gene. This alteration results from a C to G substitution at nucleotide position 61, causing the glutamine (Q) at amino acid position 21 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.56
CADD
Benign
8.7
DANN
Benign
0.84
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.94
Eigen_PC
Benign
-0.99
FATHMM_MKL
Benign
0.018
N
LIST_S2
Benign
0.41
T
M_CAP
Benign
0.00085
T
MetaRNN
Benign
0.085
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
0.0
N
MutationTaster
Benign
1.0
N;N
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-1.3
N
REVEL
Benign
0.024
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
0.10
B
Vest4
0.27
MutPred
0.19
Gain of catalytic residue at P25 (P = 0.0099);
MVP
0.014
MPC
0.21
ClinPred
0.13
T
GERP RS
0.99
Varity_R
0.27
gMVP
0.0043

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-92816404; API